World Sickle Cell Day is observed on 19 June every year under UN General Assembly resolution 63/237 of 22 December 2008; it was first observed in 2009.
Sickle cell disease is an autosomal recessive disorder caused by a mutation in the beta-globin (HBB) gene that produces haemoglobin S.
India's National Sickle Cell Anaemia Elimination Mission (launched 1 July 2023, Shahdol, MP) aims to eliminate the disease as a public health problem by 2047.
India launched BIRSA 101, its first indigenous CRISPR gene therapy for sickle cell disease, developed by CSIR-IGIB, on 19 November 2025.
HbS makes haemoglobin clump when oxygen is low, so red cells turn rigid and crescent-shaped. They block small vessels, causing pain crises and organ damage, and break down early, causing chronic anaemia. Carriers are partly protected against falciparum malaria, which keeps the gene common.
Simple Analogy: Flexible coins slide through a slot; bent ones jam it.
Eliminate sickle cell disease as a public health problem by 2047
Key: Announced in Budget 2023-24; launched by PM Modi at Shahdol, MP on 1 July 2023; screens 7 crore people aged 0-40 in 17 high-burden States; MoHFW with the Ministry of Tribal Affairs
Record each screened person as normal, carrier or diseased
Key: Encourages matching of status before marriage to prevent affected births
Indigenous CRISPR-based gene therapy for sickle cell disease
Key: Developed by CSIR-IGIB on its enFnCas9 platform; named for Bhagwan Birsa Munda's 150th birth anniversary; launched 19 November 2025; tech transfer to Serum Institute of India
Recognised sickle cell anaemia as a public health problem and called for awareness on 19 June every year.
Lists sickle cell disease among the blood disorders in its 21 specified disabilities, opening entitlements to patients.
Prevalence is highest among tribal communities of central and western India, so the mission runs jointly with the Ministry of Tribal Affairs.
Casgevy, approved in the UK in November 2023, was the world's first licensed CRISPR therapy and targets sickle cell disease; BIRSA 101 is India's indigenous counterpart.
On 19 June 2026 the President announced at Omkareshwar that NSCAEM had met its 7 crore screening target ahead of schedule - see the PIB article for the figures.
GS Paper II > Health, vulnerable sections; GS Paper III > Biotechnology
General Awareness > Important days; Biology > Human diseases
The abnormal haemoglobin made by the sickle mutation in the HBB gene.
Inheritance in which disease appears only with two copies of the faulty gene, one from each parent.
Editing a patient's own blood stem cells so they make healthy haemoglobin, then reinfusing them.